OBT announces phase 1 trial for head and neck cancer patients
The collaboration will see a new Phase 1b trial undertaken, investigating OBT’s lead asset, OBT076, in patients with Adenoid Cystic Carcinoma (ACC), a rare and aggressive type of cancer
The collaboration will see a new Phase 1b trial undertaken, investigating OBT’s lead asset, OBT076, in patients with Adenoid Cystic Carcinoma (ACC), a rare and aggressive type of cancer
The grant from the Medical Technology Enterprise Consortium (MTEC) will support the continued development of its fully portable handheld DeepView device
Brouhaha continue their progress with prestigious inclusion.
It is hoped that these reagents will help combat the growing wave of deaths in North America attributable to synthetic opioids
The initial administration of Arecor’s insulin candidate to a patient marks a significant step forward in the quest to transform the management of type 2 diabetes.
Their new film stars Jude Law, Alicia Vikander and Simon Russell Beale and is directed by Karim Aïnouz
CEO, John Glencross quoted in this article regarding the potential removal of the sunset clause.
Modi-1 cancer vaccine showed partial response and stable disease in patients with hard-to-treat head and neck, high grade serous ovarian or triple negative breast cancers.
John Glencross, Chief Executive of Calculus, is quoted in City AM, speaking about how EIS can mitigate inheritance tax.
New Calculus portfolio company Artic Shores helps companies revolutionise recruitment through their innovative technology.